About
Orizuru Therapeutics develops regenerative medicine therapies focused on iPSC-derived islets and cardiomyocytes, aiming to restore cell function for type 1 diabetes and other conditions.
Explore Orizuru Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.